Kintz Samuel (CIK 1967168) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-11-19). Recent activity: Sell ELVN (12,500 shares), Sell ELVN (12,500 shares), Sell ELVN (3,700 shares), Sell ELVN (2,800 shares), Sell ELVN (5,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-19 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 12,500 | $272,750 |
| 2025-10-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 12,500 | $266,625 |
| 2025-09-30 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 3,700 | $74,222 |
| 2025-09-25 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 2,800 | $56,084 |
| 2025-09-19 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 5,000 | $95,450 |
| 2025-09-19 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 1,000 | $20,250 |
| 2025-08-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 1,517 | $30,340 |
| 2025-08-20 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 10,393 | $208,068 |
| 2025-08-20 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 590 | $11,800 |
| 2025-07-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 4,150 | $89,557 |
| 2025-07-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 4,687 | $106,348 |
| 2025-07-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 3,663 | $85,604 |
| 2025-06-18 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 10,502 | $231,884 |
| 2025-06-18 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 1,998 | $45,454 |
| 2025-06-05 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 7,500 | $150,375 |
| 2025-05-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 5,000 | $82,450 |
| 2025-05-05 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 5,330 | $107,026 |
| 2025-05-05 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 2,170 | $43,400 |
| 2025-04-21 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 5,000 | $82,100 |
| 2025-03-19 | Enliven Therapeutics, Inc. (ELVN) | PRESIDENT AND CEO | Sell | 12,500 | $260,375 |
Source: SEC Form 4 filings · as of 2025-11-19